Search Results - "Thomas, Martin G"

Refine Results
  1. 1

    Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomere by Martin, Thomas G., Kirk, Jonathan A.

    “…The sarcomere is the basic contractile unit of striated muscle and is a highly ordered protein complex with the actin and myosin filaments at its core…”
    Get full text
    Journal Article
  2. 2

    Facile and Scalable Preparation of Pure and Dense DNA Origami Solutions by Stahl, Evi, Martin, Thomas G., Praetorius, Florian, Dietz, Hendrik

    Published in Angewandte Chemie International Edition (17-11-2014)
    “…DNA has become a prime material for assembling complex three‐dimensional objects that promise utility in various areas of application. However, achieving…”
    Get full text
    Journal Article
  3. 3

    Synthetic Lipid Membrane Channels Formed by Designed DNA Nanostructures by Langecker, Martin, Arnaut, Vera, Martin, Thomas G., List, Jonathan, Renner, Stephan, Mayer, Michael, Dietz, Hendrik, Simmel, Friedrich C.

    “…We created nanometer-scale transmembrane channels in lipid bilayers by means of self-assembled DNA-based nanostructures. Scaffolded DNA origami was used to…”
    Get full text
    Journal Article
  4. 4

    Kidney Injury and Repair Biomarkers in Marathon Runners by Mansour, Sherry G., DO, Verma, Gagan, MPH, Pata, Rachel W., DPT, CCS, Martin, Thomas G., PhD, Perazella, Mark A., MD, Parikh, Chirag R., MD, PhD

    Published in American journal of kidney diseases (01-08-2017)
    “…Background Investigation into strenuous activity and kidney function has gained interest given increasing marathon participation. Study Design Prospective…”
    Get full text
    Journal Article
  5. 5

    Cryo-EM structure of a 3D DNA-origami object by Bai, Xiao-chen, Martin, Thomas G, Scheres, Sjors H. W, Dietz, Hendrik

    “…A key goal for nanotechnology is to design synthetic objects that may ultimately achieve functionalities known today only from natural macromolecular…”
    Get full text
    Journal Article
  6. 6

    Molecular transport through large-diameter DNA nanopores by Krishnan, Swati, Ziegler, Daniela, Arnaut, Vera, Martin, Thomas G., Kapsner, Korbinian, Henneberg, Katharina, Bausch, Andreas R., Dietz, Hendrik, Simmel, Friedrich C.

    Published in Nature communications (23-09-2016)
    “…DNA-based nanopores are synthetic biomolecular membrane pores, whose geometry and chemical functionality can be tuned using the tools of DNA nanotechnology,…”
    Get full text
    Journal Article
  7. 7

    Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover by Martin, Thomas G., Myers, Valerie D., Dubey, Praveen, Dubey, Shubham, Perez, Edith, Moravec, Christine S., Willis, Monte S., Feldman, Arthur M., Kirk, Jonathan A.

    Published in Nature communications (19-05-2021)
    “…The association between reduced myofilament force-generating capacity (F max ) and heart failure (HF) is clear, however the underlying molecular mechanisms are…”
    Get full text
    Journal Article
  8. 8

    Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma by Baz, Rachid C., Martin, Thomas G., Lin, Hui-Yi, Zhao, Xiuhua, Shain, Kenneth H., Cho, Hearn J., Wolf, Jeffrey L., Mahindra, Anuj, Chari, Ajai, Sullivan, Daniel M., Nardelli, Lisa A., Lau, Kenneth, Alsina, Melissa, Jagannath, Sundar

    Published in Blood (26-05-2016)
    “…Pomalidomide and low-dose dexamethasone (PomDex) is standard treatment of lenalidomide refractory myeloma patients who have received >2 prior therapies. We…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Cryo-EM structure of lysenin pore elucidates membrane insertion by an aerolysin family protein by Bokori-Brown, Monika, Martin, Thomas G., Naylor, Claire E., Basak, Ajit K., Titball, Richard W., Savva, Christos G.

    Published in Nature communications (06-04-2016)
    “…Lysenin from the coelomic fluid of the earthworm Eisenia fetida belongs to the aerolysin family of small β-pore-forming toxins (β-PFTs), some members of which…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Design of a molecular support for cryo-EM structure determination by Martin, Thomas G., Bharat, Tanmay A. M., Joerger, Andreas C., Bai, Xiao-chen, Praetorius, Florian, Fersht, Alan R., Dietz, Hendrik, Scheres, Sjors H. W.

    “…Despite the recent rapid progress in cryo-electron microscopy (cryo-EM), there still exist ample opportunities for improvement in sample preparation…”
    Get full text
    Journal Article
  14. 14

    Revealing the structures of megadalton-scale DNA complexes with nucleotide resolution by Kube, Massimo, Kohler, Fabian, Feigl, Elija, Nagel-Yüksel, Baki, Willner, Elena M., Funke, Jonas J., Gerling, Thomas, Stömmer, Pierre, Honemann, Maximilian N., Martin, Thomas G., Scheres, Sjors H. W., Dietz, Hendrik

    Published in Nature communications (04-12-2020)
    “…The methods of DNA nanotechnology enable the rational design of custom shapes that self-assemble in solution from sets of DNA molecules. DNA origami, in which…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cryo-EM structure of a metazoan separase–securin complex at near-atomic resolution by Boland, Andreas, Martin, Thomas G, Zhang, Ziguo, Yang, Jing, Bai, Xiao-chen, Chang, Leifu, Scheres, Sjors H W, Barford, David

    Published in Nature structural & molecular biology (01-04-2017)
    “…Cryo-EM analyses provide a near-atomic view of the C. elegans securin–separase complex, with insights into the mechanism by which securin inhibits separase's…”
    Get full text
    Journal Article
  17. 17

    Phase Ib Dose-Escalation Study (PX-171-006) of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Progressive Multiple Myeloma by NIESVIZKY, Ruben, MARTIN, Thomas G, BENSINGER, William I, ALSINA, Melissa, SIEGEL, David S, KUNKEL, Lori A, WONG, Alvin F, LEE, Susan, ORLOWSKI, Robert Z, WANG, Michael

    Published in Clinical cancer research (15-04-2013)
    “…Carfilzomib, a selective proteasome inhibitor, has shown safety and efficacy in relapsed and/or refractory multiple myeloma. This phase I study in patients…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma by Banerjee, Rahul, Lo, Mimi, Martin, 3rd, Thomas G

    Published in Future oncology (London, England) (01-12-2021)
    “…The treatment of relapsed multiple myeloma remains challenging. Based on interim data from the randomized Phase III IKEMA study demonstrating a…”
    Get full text
    Journal Article
  20. 20